PneumoADIP

From Wikipedia, the free encyclopedia

Pneumococcal vaccines Accelerated Development and Introduction Plan (PnemoADIP) is a small, dedicated team based at Johns Hopkins Bloomberg School of Public Health and is supported by a $30 million grant from the Global Alliance for Vaccines and Immunization. Its mission is to improve child survival and health by accelerating the evaluation of and access to new, lifesaving pneumococcal vaccines for the world's children.

PneumoADIP aims to achieve its goals through partnerships with countries, donors, academia, international organizations and industry. PneumoADIP coordinates its activities through a strategic alliance with the World Health Organization.

[edit] External links

PneumoADIP - Pneumococcal vaccines Accelerated Development and Introduction Plan

v • d • e Vaccines, Vaccination, Immunization, and Inoculation

Development	Adjuvants • Cancer vaccines • DNA vaccination • HIV • Live vector vaccine • Models • Timeline • Trial

Administration	ACIP • GAVI • VAERS • Vaccine court • Vaccine injury • Policy • Schedule • VSD

Live vaccines	Anthrax • BCG • Flu • MMR • MMRV • Polio(OPV) • Smallpox • Varicella • Yellow fever

Inactivated/toxoid vaccines	inactivated virus: Flu • HAV • Polio(IPV) •• inactivated bacteria/toxoid: DTwP •• conjugate: Hib • PCV

Other vaccines	subunit: Anthrax • DTaP • HPV •• recombinant DNA: HBV •• other: Anthrax • PPV

Controversy	General • A-CHAMP • MMR • NCVIA • Pox party • Safe Minds • Thiomersal

See also	List of vaccine topics • Epidemiology